durvalumab,Tremelimumab
astrazeneca
new data from our himalaya and topaz-1 phase iii trials for people living with #gicancers were presented at #ilc2022 and #wcgic2022. learn more about this important data: 
The official Twitter feed for AstraZeneca US. For more info visit http://t.co/5VlUaVGyiC.